Introduction The understanding of atopic dermatitis (AD) pathogenesis has rapidly
expanded in recent years, catalyzing the development of new targeted monoclonal antibody …

Atopic dermatitis (AD) is a complex and heterogeneous inflammatory skin disorder with a
profound symptom and lesional burden. Moderate-to-severe AD is particularly challenging …

Introduction: Atopic dermatitis (AD) is a chronic inflammatory skin condition, affecting a
significant number of patients of all ages. As we learn more about the pathogenesis of AD …

Atopic dermatitis (AD) is a debilitating disease that significantly alters the quality of life for
one in four children and one in 10 adults. Current management of AD utilizes combinations …

Atopic dermatitis is a common immunologic skin disease. Mild atopic dermatitis can be
managed with emollients and topical therapies such as low potency topical steroids, which …

Introduction A comprehensive review of the English-language medical literature was
performed searching for ongoing and closed clinical trials concerning new and emerging …

Atopic dermatitis (AD) is an inflammatory skin disease arising from a complex interplay of
genetic, immune, and environmental factors. The development and successful marketing of …

Monoclonal antibodies for the treatment of atopic dermatitis : Current Opinion in Allergy and
Clinical Immunology Monoclonal antibodies for the treatment of atopic dermatitis : Current …

Introduction: Atopic dermatitis (AD) is a common skin disease. Although most patients are
well served by existing therapies, a subset of patients with severe AD are still not adequately …

Background The mainstay of atopic dermatitis treatment has been largely unchanged over
the last few decades. With improved understanding of the immunologic pathways underlying …